Orthobiologics represent a promising frontier in regenerative medicine that uses biologically derived substances to help stimulate healing and repair in musculoskeletal tissues. We explore its growth, key drivers, and the burgeoning opportunities for investors in this innovative field of medicine.
Read more
PRP, BMAC, and MFAT (microfat) are the three primary regenerative medicine substances. The pros and cons of each are briefly discussed.
Read more
Dr. Mitchell Sheinkop discusses Jointechlabs’ recent presentation of scientific papers at orthobiologic conferences in Europe.
Read more
The rising global market for regenerative medicine not only offers hope in the form of advanced therapies but also presents a fertile ground for robust investment returns.
Read more
Jointechlabs earned the MDSAP quality certification indicating compliance with ISO13485:2016 for medical device quality management.
Read more
English 
Deutsch 
Italiano